Size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy

Chemotherapy is a traditional treatment method in clinical cancer treatment. However, it is limited due to the large toxic side effects of chemotherapeutics. Nanomedicines have shown great potential in the application of tumor therapy. The size of nanoparticles as a crucial factor in the enhanced pe...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Meng Gao, Yue Chen, Chenghu Wu
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
Acceso en línea:https://doaj.org/article/af8fcf5186df4ec9b64cc06e102ff80d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:af8fcf5186df4ec9b64cc06e102ff80d
record_format dspace
spelling oai:doaj.org-article:af8fcf5186df4ec9b64cc06e102ff80d2021-11-17T14:21:59ZSize-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy2165-59792165-598710.1080/21655979.2021.2006568https://doaj.org/article/af8fcf5186df4ec9b64cc06e102ff80d2021-11-01T00:00:00Zhttp://dx.doi.org/10.1080/21655979.2021.2006568https://doaj.org/toc/2165-5979https://doaj.org/toc/2165-5987Chemotherapy is a traditional treatment method in clinical cancer treatment. However, it is limited due to the large toxic side effects of chemotherapeutics. Nanomedicines have shown great potential in the application of tumor therapy. The size of nanoparticles as a crucial factor in the enhanced permeability and retention (EPR) effect can be regulated for the enhanced chemotherapy. Therefore, we believe that regulation of nanoparticle size can be used as an effective sensitizer to enhance the therapeutic effect of chemotherapy drugs on tumors. Here, we prepared several nanoparticles of different hydrodynamic diameters commonly found in nanomedical applications by the diblock copolymer of methoxy polyethylene glycol- poly (ϵ‐caprolactone) (mPEG-PCL). The blood circulation effect and organ distribution in blood were detected by fluorescence labeled nanoparticles. We found that the small-sized nanoparticles exhibited much longer blood circulation time than the large-sized nanoparticles in vivo, and thus the nanoparticle concentration in the tumor tissue was relatively high. Systematic injection of the doxorubicin (DOX) loaded nanoparticles can effectively inhibit tumor growth. Compared to the free drug, tumor cells were much more sensitive to DOX loaded nanoparticles of small size. Our nano-drug delivery system has been proven to be safe and non-toxic in vivo and was suitable for use as a sensitizer in clinical oncology chemotherapy.Meng GaoYue ChenChenghu WuTaylor & Francis Grouparticlemalignant gliomadoxorubicin-loaded nanoparticleschemosensitizationtumor chemotherapysize-dependentBiotechnologyTP248.13-248.65ENBioengineered, Vol 0, Iss 0 (2021)
institution DOAJ
collection DOAJ
language EN
topic malignant glioma
doxorubicin-loaded nanoparticles
chemosensitization
tumor chemotherapy
size-dependent
Biotechnology
TP248.13-248.65
spellingShingle malignant glioma
doxorubicin-loaded nanoparticles
chemosensitization
tumor chemotherapy
size-dependent
Biotechnology
TP248.13-248.65
Meng Gao
Yue Chen
Chenghu Wu
Size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy
description Chemotherapy is a traditional treatment method in clinical cancer treatment. However, it is limited due to the large toxic side effects of chemotherapeutics. Nanomedicines have shown great potential in the application of tumor therapy. The size of nanoparticles as a crucial factor in the enhanced permeability and retention (EPR) effect can be regulated for the enhanced chemotherapy. Therefore, we believe that regulation of nanoparticle size can be used as an effective sensitizer to enhance the therapeutic effect of chemotherapy drugs on tumors. Here, we prepared several nanoparticles of different hydrodynamic diameters commonly found in nanomedical applications by the diblock copolymer of methoxy polyethylene glycol- poly (ϵ‐caprolactone) (mPEG-PCL). The blood circulation effect and organ distribution in blood were detected by fluorescence labeled nanoparticles. We found that the small-sized nanoparticles exhibited much longer blood circulation time than the large-sized nanoparticles in vivo, and thus the nanoparticle concentration in the tumor tissue was relatively high. Systematic injection of the doxorubicin (DOX) loaded nanoparticles can effectively inhibit tumor growth. Compared to the free drug, tumor cells were much more sensitive to DOX loaded nanoparticles of small size. Our nano-drug delivery system has been proven to be safe and non-toxic in vivo and was suitable for use as a sensitizer in clinical oncology chemotherapy.
format article
author Meng Gao
Yue Chen
Chenghu Wu
author_facet Meng Gao
Yue Chen
Chenghu Wu
author_sort Meng Gao
title Size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy
title_short Size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy
title_full Size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy
title_fullStr Size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy
title_full_unstemmed Size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy
title_sort size-dependent chemosensitization of doxorubicin-loaded polymeric nanoparticles for malignant glioma chemotherapy
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/af8fcf5186df4ec9b64cc06e102ff80d
work_keys_str_mv AT menggao sizedependentchemosensitizationofdoxorubicinloadedpolymericnanoparticlesformalignantgliomachemotherapy
AT yuechen sizedependentchemosensitizationofdoxorubicinloadedpolymericnanoparticlesformalignantgliomachemotherapy
AT chenghuwu sizedependentchemosensitizationofdoxorubicinloadedpolymericnanoparticlesformalignantgliomachemotherapy
_version_ 1718425437019832320